Corgenix specializes in high quality laboratory assays for the detection and evaluation of autoimmune and vascular diseases, bleeding and thrombotic disorders, chronic liver disease and infectious diseases. Corgenix pioneered the field of antiphospholipid antibody testing in 1990 with the development of the first commercial anticardiolipin antibody assay in the US, and continues to be a leader in this arena.


* Denotes a product that has not been cleared for in vitro diagnostic use in the United States by the U.S. Food and Drug Administration. In all countries where the use of this product has not been cleared, the product shall not be used for diagnostic use as performance characteristics have not been established.